"Luteolin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
5,7,3',4'-tetrahydroxy-flavone, one of the FLAVONES.
| Descriptor ID |
D047311
|
| MeSH Number(s) |
D03.383.663.283.266.450.260.555 D03.633.100.150.266.450.260.555
|
| Concept/Terms |
Luteolin- Luteolin
- 3',4',5,7-Tetrahydroxy-Flavone
- 3',4',5,7-Tetrahydroxyflavone
- Luteoline
|
Below are MeSH descriptors whose meaning is more general than "Luteolin".
Below are MeSH descriptors whose meaning is more specific than "Luteolin".
This graph shows the total number of publications written about "Luteolin" by people in this website by year, and whether "Luteolin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Luteolin" by people in Profiles.
-
Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells. RNA Biol. 2018; 15(11):1420-1432.
-
Protein-Flavonoid Interaction Studies by a Taylor Dispersion Surface Plasmon Resonance (SPR) Technique: A Novel Method to Assess Biomolecular Interactions. Biosensors (Basel). 2016 Feb 25; 6(1).
-
Luteolin suppresses development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats. Oncol Rep. 2016 Feb; 35(2):825-32.
-
Exploring quercetin and luteolin derivatives as antiangiogenic agents. Eur J Med Chem. 2015 Jun 05; 97:259-74.